Forge Biologics

Acquired

Gene Therapy CDMO

Grove City, United States · Founded 2020 · $250.0M raised

Headquarters
Grove City, Ohio
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$250.0M
Last Round
$90.0M Series CJan 2024
Rounds
3
Acquisition Date
Nov 2023

About

Forge Biologics is a US-based gene therapy CDMO and member of the Ajinomoto Group, delivering comprehensive AAV manufacturing services from early development through clinical trials and commercial production. Founded in 2020 by gene therapy developers, Forge combines firsthand development expertise with deep AAV manufacturing capabilities to help therapy developers bring treatments from concept to patient.

Summary

Forge Biologics is a Biotech company based in Grove City, United States, founded in 2020. It has raised $250.0M in total across 3 rounds, most recently a $90.0M Series C round in Jan 2024. Investors include Drive Capital, Perceptive Advisors and Aisling Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2024
$90.0M

Sign up to see all 4 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Forge Biologics on Indexed.vc
<a href="https://indexed.vc/companies/forge-biologics"><img src="https://indexed.vc/api/badge/company/forge-biologics" alt="Forge Biologics on Indexed.vc" width="260" height="76" /></a>